CWC25 Antibody

What is CWC25 and what functional role does it play in pre-mRNA splicing?

CWC25 is a splicing factor that plays a crucial role in modulating the conformation of the catalytic spliceosome. Research has conclusively demonstrated that CWC25 is required for the first catalytic step of pre-mRNA splicing, specifically functioning after the actions of Prp2 and Yju2 . CWC25 stabilizes the post-first-step conformation of the spliceosome, with its presence inhibiting both the reverse first step reaction and forward second step reaction .

Mechanistically, CWC25 becomes stably associated with the spliceosome after the first catalytic reaction, indicating its important role in maintaining the structural integrity of the post-first-step splicing complex . While CWC25 was initially identified as associating with Cef1/Ntc85 (a component of the Prp19-associated complex), experimental evidence shows it is not an intrinsic component of the NTC, as it does not stably associate with Prp19 or other NTC components in significant amounts .

What detection methods are most effective when working with CWC25 antibody?

Researchers have successfully employed multiple techniques with CWC25 antibodies. Based on available literature and product information, CWC25 antibody can be effectively used in:

• Western blot (WB): Successful detection of CWC25 in HeLa cells with an observed molecular weight of approximately 50 kDa .

• Immunohistochemistry (IHC): Positive detection in human testis tissue and human cervical cancer tissue .

• Immunofluorescence (IF): Effective detection in HepG2 cells .

• ELISA: Validated for quantitative detection .

• Immunoprecipitation (IP): Successfully used to isolate spliceosomes and study CWC25 association with splicing complexes .

When using these methods, it's essential to include proper controls, particularly when studying the dynamics of CWC25 association with spliceosomes at different stages.

What experimental models are suitable for studying CWC25 function?

Based on the research literature, several experimental models have proven effective for studying CWC25:

• Yeast systems: Much of the foundational work on CWC25 has been performed in yeast models, including strains like BJ2168 (MATa prc1 prb1 pep4 leu2 trp1 ura3), YSCC1, YSCC12, and YSCC25 .

• Human cell lines: The CWC25 antibody has been validated to work in human cell lines including HeLa and HepG2 cells .

• In vitro splicing systems: Researchers have successfully used cell-free splicing extracts to study CWC25 function through immunodepletion and complementation assays .

Species reactivity of commercially available antibodies includes human and mouse systems, which provides flexibility in experimental design across different model organisms .

How does CWC25 modulate spliceosome conformation during the catalytic phase?

CWC25 plays a central role in stabilizing the post-first-step conformation of the spliceosome. Research has provided several key insights into its mechanism:

• Conformational stabilization: When CWC25 binds to the spliceosome, it locks the complex in the post-first-step conformation. Experimental evidence shows that adding recombinant CWC25 to Cwc25-free first-step spliceosomes inhibits both the forward second-step reaction and the reverse first-step reaction .

• Reversible binding: The binding of CWC25 to the spliceosome is reversible. Studies have shown that CWC25 can dissociate from and reassociate with the spliceosome. After Prp16-mediated dissociation, CWC25 can rebind to the spliceosome in the absence of Slu7 .

• Conformational switching: In the absence of CWC25, the spliceosome demonstrates dynamic conformational flexibility, being able to catalyze both the forward second reaction and the reverse first reaction. This indicates that CWC25 restricts conformational changes essential for transitioning between different catalytic states .

These findings collectively demonstrate that CWC25 functions as a critical conformational modulator that helps maintain the spliceosome in a specific configuration after the first catalytic step.

How does tagging CWC25 affect its function and association with the spliceosome?

Tagging CWC25 can significantly impact its function and interaction with the spliceosome, providing important insights for experimental design:

• N-terminal tagging effects: Research has shown that N-terminal tagging of CWC25 with four copies of the V5-tag (4V5-Cwc25) strongly biases the splicing reaction toward the reverse reaction. This suggests that the N-terminus of CWC25 is crucial for its proper interaction with the spliceosome .

• Dissociation dynamics: The V5-tagged CWC25 (4V5-Cwc25) is prone to dissociate from the spliceosome upon incubation, with over 70% separating from the complex under certain conditions. This dissociation occurs independently of the reverse reaction, whether associated with pre-mRNA or splicing intermediates .

• C-terminal tagging: C-terminal tagging appears to be less disruptive. In experiments, recombinant CWC25 with a His-tag at the C-terminus was used effectively to study inhibition of both forward and reverse reactions . Similarly, HA-tagging at the C-terminus has been successfully used to study CWC25's association with the spliceosome .

These observations highlight the importance of tag placement when studying CWC25 and suggest that researchers should carefully consider tagging strategies to minimize functional interference.

What is the relationship between CWC25 and other spliceosome components?

CWC25 interacts with several spliceosome components in a specific temporal and functional sequence:

• Relationship with NTC components: Although CWC25 was identified as associating with Cef1/Ntc85, immunoprecipitation analysis revealed that CWC25 is not stably associated with Prp19 or other NTC components in significant amounts. Even Ntc85/Cef1 was not coprecipitated with CWC25 in substantial quantities .

• Isy1/Ntc30 and Ntc20 interactions: Components of the Prp19-associated complex, specifically Isy1/Ntc30 and Ntc20, stabilize the association of CWC25 with the spliceosome. Their absence can bypass the requirement of Prp16 for the second step of splicing .

• Sequential action with Prp2 and Yju2: CWC25 functions after Prp2 and Yju2 in the splicing pathway. Prp2 mediates the destabilization of SF3a/b, followed by Yju2 action, and then CWC25 becomes involved for the first catalytic reaction .

• Association with splicing intermediates: Immunoprecipitation studies show that CWC25 is associated only with splicing complexes containing splicing intermediates, supporting its role specifically in the first catalytic step .

Understanding these relationships is crucial for designing experiments to investigate the mechanistic details of CWC25 function within the complex spliceosome assembly.

What are the optimal conditions for using CWC25 antibody in immunoprecipitation experiments?

For effective immunoprecipitation experiments using CWC25 antibody, researchers should consider:

• Antibody coupling: Anti-CWC25 antibody should be coupled to protein A-Sepharose. Based on published protocols, approximately 100 μl of anti-CWC25 antiserum coupled to 50 μl of protein A-Sepharose is effective for immunodepletion from 100 μl of splicing extracts .

• Precipitation conditions: For isolating spliceosomes containing CWC25, immunoprecipitation can be performed with anti-HA antibody (when using CWC25-HA tagged strains) or with anti-CWC25 antibody directly. The precipitated complexes can then be analyzed by Western blotting or RNA extraction to examine associated components .

• ATP considerations: To retain CWC25 on the spliceosome during immunoprecipitation, ATP depletion before immunoprecipitation can be beneficial. Research has shown that a much larger amount of CWC25 accumulates on the spliceosome after ATP depletion .

• Washing conditions: After precipitation, the spliceosome should be washed with buffer containing appropriate salt concentrations. Published protocols often use buffer DK without glycerol, containing 4 mM MgCl₂ and/or 0.1 mM MnCl₂, 0.8 units/μl RNasin, and 50 μg/ml tRNA .

Following these conditions will help ensure specific isolation of CWC25-associated spliceosomes for further analysis.

How can researchers effectively deplete CWC25 from splicing extracts?

For successful immunodepletion of CWC25 from splicing extracts:

• Antibody preparation: Use anti-CWC25 antiserum coupled to protein A-Sepharose. Based on published protocols, incubate 100 μl of splicing extracts with 100 μl of anti-CWC25 antiserum coupled to 50 μl of protein A-Sepharose .

• Validation: After depletion, confirm the absence of CWC25 by Western blotting. It's important to verify that other essential splicing factors were not significantly co-depleted .

• Functional testing: The effectiveness of depletion can be functionally assessed by conducting in vitro splicing assays. Properly depleted extracts should show abolished splicing activity that can be restored upon addition of recombinant CWC25 .

• Controls: Include mock-depleted extracts as controls to ensure that any observed effects are specifically due to the absence of CWC25 rather than general disruption of the splicing machinery .

This methodology has been successfully employed to demonstrate that CWC25 is required for the in vitro splicing reaction, and its depletion does not significantly co-deplete other essential splicing factors .

What complementation assays can be used to study CWC25 function?

Complementation assays are powerful tools for studying CWC25 function:

• Spliceosome isolation and complementation: Spliceosomes formed in CWC25-depleted extracts can be isolated by precipitation with anti-Ntc20 antibody. The addition of recombinant CWC25 to these isolated spliceosomes promotes the first catalytic reaction, demonstrating the specific requirement for CWC25 in this step .

• Reaction conditions: For effective complementation, the isolated spliceosomes should be incubated at 25°C for approximately 20 minutes in buffer containing 4 mM MgCl₂, with the addition of recombinant CWC25 (approximately 150 ng) .

• Combined factor analysis: Complementation assays can also be used to study the interplay between CWC25 and other splicing factors. For example, adding both recombinant Yju2 and CWC25 to spliceosomes formed in Yju2-depleted extracts can help determine their functional relationship .

• Kinetic analysis: By analyzing the kinetics of the splicing reaction after complementation with CWC25, researchers can gain insights into the role of CWC25 in stabilizing specific spliceosome conformations .

These complementation approaches provide valuable information about the functional requirements and mechanistic details of CWC25 in pre-mRNA splicing.

How can researchers distinguish between direct and indirect effects of CWC25 on splicing?

Distinguishing direct from indirect effects of CWC25 requires multiple complementary approaches:

• Purified spliceosome systems: Using affinity-purified spliceosomes from CWC25-depleted extracts followed by addition of recombinant CWC25 can demonstrate direct effects. If addition of CWC25 alone is sufficient to promote the first catalytic reaction, this suggests a direct role .

• Structure-function analysis: Creating mutants or tagged versions of CWC25 can help identify which domains are directly involved in splicing. For example, the observation that N-terminal tagging of CWC25 affects its function differently than C-terminal tagging provides insights into which regions directly interact with the spliceosome .

• Time-course experiments: Analyzing the kinetics of splicing reactions after CWC25 addition can help distinguish direct from indirect effects. Direct effects typically manifest more rapidly than indirect effects that require intermediate steps .

• Interaction studies: Combining immunoprecipitation with Western blotting to identify proteins that directly interact with CWC25 can distinguish direct binding partners from proteins that are affected indirectly through conformational changes .

By employing these strategies, researchers can build a more detailed understanding of CWC25's direct mechanistic role in splicing versus its indirect effects through interaction with other factors.

What strategies can be employed to study the dynamics of CWC25 association with the spliceosome?

Several strategies can effectively monitor CWC25's dynamic association with the spliceosome:

• ATP depletion studies: Research has shown that ATP depletion after the splicing reaction significantly affects CWC25 association with the spliceosome. In Slu7-depleted extracts, a much larger amount of CWC25 accumulates on the spliceosome after ATP depletion .

• Tagged protein systems: Using epitope-tagged CWC25 (such as HA-tagged or V5-tagged versions) allows for tracking its association with the spliceosome at different stages. This approach has revealed that CWC25 becomes stably associated with the spliceosome after the first reaction .

• Immunoprecipitation at different stages: Performing immunoprecipitation with antibodies against different spliceosome components (e.g., Ntc20, Yju2, or CWC25 itself) at various stages of the splicing reaction can provide insights into the dynamic composition of the spliceosome .

• Supernatant/pellet analysis: After incubation of purified spliceosomes, separating and analyzing the supernatant and pellet fractions can reveal the dissociation dynamics of CWC25. For example, studies have shown that >70% of 4V5-CWC25 separates from the spliceosome under certain conditions .

These approaches collectively provide a comprehensive view of how CWC25 associates with and dissociates from the spliceosome during the splicing cycle.

How should researchers interpret contradictory results regarding CWC25 function in different experimental systems?

When faced with contradictory results about CWC25 function:

• Consider species-specific differences: Although CWC25's fundamental role in splicing is conserved, there may be species-specific variations in its exact mechanism or regulation. Compare results between yeast and mammalian systems carefully, noting that the CWC25 antibody has been validated to work with both human and mouse samples .

• Evaluate experimental conditions: Different buffer conditions, particularly pH and salt concentrations, can significantly affect CWC25's function. For example, the reverse splicing reaction shows different kinetics depending on KCl concentration and pH .

• Assess protein tagging effects: As demonstrated in the literature, N-terminal tagging of CWC25 (4V5-CWC25) can strongly bias the splicing reaction toward the reverse reaction, while C-terminal tagging may have different effects . Consider how tagging strategies might influence contradictory results.

• Examine spliceosome composition: The presence or absence of other splicing factors (such as Isy1/Ntc30 and Ntc20, which stabilize CWC25 association) can significantly impact CWC25 function and might explain contradictory results .

By systematically evaluating these factors, researchers can reconcile apparently contradictory results and develop a more comprehensive understanding of CWC25's role in different contexts.